BIOANALYTICAL SYS INC's ticker is BASI and the CUSIP is 09058M103. A total of 20 filers reported holding BIOANALYTICAL SYS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 110,000 | $270,000 | 0.02% |
| Versant Capital Management, Inc | 19,191 | $47,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 178,510 | $441,000 | 0.01% |
| Virtu Financial LLC | 32,214 | $79,000 | 0.00% |
| NORTH STAR ASSET MANAGEMENT INC | 15,000 | $37,000 | 0.00% |
| Renaissance Technologies | 244,200 | $598,000 | 0.00% |
| UBS Group AG | 394 | $1,000 | 0.00% |
| Advisor Group, Inc. | 100 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 52 | $0 | 0.00% |
| STATE STREET CORP | 10,200 | $25,000 | 0.00% |